Brodalumab
Brodalumab is a human monoclonal antibody designed for the treatment of inflammatory diseases. As of January 2016 it is awaiting an FDA decision on its use for the treatment of moderate to severe psoriasis.
primaryTopic
Brodalumab
Brodalumab is a human monoclonal antibody designed for the treatment of inflammatory diseases. As of January 2016 it is awaiting an FDA decision on its use for the treatment of moderate to severe psoriasis.
has abstract
Brodalumab is a human monoclon ...... moderate to severe psoriasis.
@en
Le brodalumab est un anticorps ...... médicament dans le psoriasis.
@fr
برودالوماب هو جسم مضاد وحيد النسيلة مصمم لعلاج أمراض التهابية طورته آمجن.
@ar
ATC prefix
ATC suffix
CAS number
1174395-19-7
Wikipage page ID
33,023,911
Wikipage revision ID
734,008,263
ChemSpiderID
legal status
Investigational
molecular weight
Verifiedfields
verifiedrevid
459,982,905
Watchedfields
subject
hypernym
comment
Brodalumab is a human monoclon ...... moderate to severe psoriasis.
@en
Le brodalumab est un anticorps ...... médicament dans le psoriasis.
@fr
برودالوماب هو جسم مضاد وحيد النسيلة مصمم لعلاج أمراض التهابية طورته آمجن.
@ar
label
Brodalumab
@en
Brodalumab
@fr
برودالوماب
@ar